BioSpace News Archive

Business

Nu Skin Enterprises Reports Second Quarter Financial Results

Nu Skin Enterprises, Inc. (NYSE: NUS) today announced second quarter 2022 results.

August 4, 2022
·
16 min read
Business

Insulet Reports Second Quarter 2022 Revenue Increase of 14% Year-Over-Year (18% Constant Currency1)

Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® brand of products, announced financial results for the three months ended June 30, 2022.

August 4, 2022
·
14 min read
Biotech Bay

Personalis to Participate at the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference

Personalis, Inc., a leader in advanced genomics for cancer, announced that its management team will participate at the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference on Tuesday, August 16, 2022.

August 4, 2022
·
1 min read
Genetown

Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Aug 04, 2022

Syros Pharmaceuticals announced the grant of a restricted stock unit award for 31,000 shares of Syros common stock to one newly hired employee in connection with the employee’s commencement of employment with Syros.

August 4, 2022
·
1 min read
Business

Cerus Corporation Announces Another Record Quarter and Reiterates Full Year 2022 Product Revenue Guidance Range

Cerus Corporation announced financial results for the second quarter ended June 30, 2022.

August 4, 2022
·
18 min read
Business

Inogen Announces Second Quarter 2022 Financial Results

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended June 30, 2022 and provided a business update.

August 4, 2022
·
14 min read
Business

Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2022 Financial Results

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today reported recent business highlights and second quarter 2022 financial results.

August 4, 2022
·
14 min read
Business

Legend Biotech Appoints Three New Directors and Elects New Chairman of the Board

Legend Biotech Corporation announced the appointment of three new directors to its Board: Mr. Tomas Heyman as Class I director of Legend Biotech, Dr. Fangliang “Frank” Zhang as Class II director of Legend Biotech, and Dr. Li Mao as Class III director of Legend Biotech.

August 4, 2022
·
5 min read
Business

Schrödinger Reports Second Quarter 2022 Financial Results

Schrödinger, Inc., whose physics-based software platform is transforming the way therapeutics and materials are discovered, announced financial results for the second quarter of 2022.

August 4, 2022
·
15 min read
Business

Omnicell Announces Financial Results for Second Quarter 2022

Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced results for its second quarter ended June 30, 2022.

August 4, 2022
·
35 min read